Wealth Enhancement Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.7M Buy
921,461
+158,322
+21% +$12.8M 0.12% 160
2026
Q1
$59.4M Sell
763,139
-92,776
-11% -$8.89M 0.12% 155
2025
Q4
$86.1M Buy
855,915
+43,664
+5% +$4.24M 0.12% 162
2025
Q3
$79.8M Buy
812,251
+242,237
+42% +$22.3M 0.12% 162
2025
Q2
$50.4M Buy
570,014
+38,955
+7% +$3.3M 0.08% 226
2025
Q1
$47.7M Buy
531,059
+53,340
+11% +$4.77M 0.09% 213
2024
Q4
$38.2M Buy
477,719
+116,310
+32% +$10.1M 0.07% 253
2024
Q3
$32.5M Sell
361,409
-7,273
-2% -$612K 0.07% 268
2024
Q2
$29M Buy
368,682
+35,995
+11% +$2.95M 0.07% 266
2024
Q1
$29M Buy
332,687
+14,524
+5% +$1.24M 0.08% 249
2023
Q4
$26.2M Sell
318,163
-85,064
-21% -$6.48M 0.08% 247
2023
Q3
$31.6M Buy
403,227
+352,309
+692% +$29.5M 0.1% 201
2023
Q2
$4.49M Buy
50,918
+21,217
+71% +$1.83M 0.05% 137
2023
Q1
$2.39M Buy
+29,701
New +$2.42M 0.03% 194
2020
Q3
Sell
-16,739
Closed -$1.63M 227
2020
Q2
$1.63M Buy
+16,739
New +$1.61M 0.05% 135
2019
Q1
Sell
-15,430
Closed -$1.35M 202
2018
Q4
$1.35M Buy
+15,430
New +$1.44M 0.09% 90

Other funds holding MDT

Wealth Enhancement Advisory Services's MDT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Medtronic (MDT) stake by 21% in Q2 2026, buying an estimated $12.8M and bringing the position to 921,461 shares worth $69.7M. The position accounts for 0.12% of the portfolio, ranked #160.

Wealth Enhancement Advisory Services first reported a position in MDT in Q4 2018 and has held it in 16 quarters since. The position peaked at $86.1M in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 921,461 shares of Medtronic worth $69.7M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 158,322 Medtronic shares in Q2 2026, an estimated $12.8M.
  • Medtronic made up 0.12% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #160 holding.
  • Wealth Enhancement Advisory Services first reported a position in Medtronic in Q4 2018 and has held it in 16 quarters since.
  • Wealth Enhancement Advisory Services's Medtronic position peaked at $86.1M in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.